News

News2021-02-12T02:26:20-05:00

Latest News

Regeltec chooses Colombia and Bioaccess™ for the first-in-human clinical trial of its HYDRAFIL system

ReGelTec, Inc., a Baltimore-based medical device startup company that is developing the next generation of minimally invasive spinal implants for lower back pain and degenerative disc disease, has chosen Colombia and bioaccess™ as its CRO to conduct the first-in-human clinical trial of its HYDRAFIL System.

Load More Posts
Go to Top